Truvian Sciences Accelerates Plans With $27.1 Million Series B Financing to Develop an Automated Benchtop Blood Testing System for Rapid Assessment of a Full Suite of Health Tests

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2qAFjCb
via IFTTT